Get Pregnant Naturally

Get Pregnant Naturally
".....Utilizing Traditional Chinese Medicine in Tonifying Energy flow to the Reproductive System Channels In Men and Women for Natural Conception, including Couple Who were diagnosed with Unexplained causes of Infertility...." Chantel M.

Permanent Unwanted Tattoo Removal by Tattoo Expert

Permanent Unwanted Tattoo Removal by Tattoo Expert
Safely, Painlessly, Laserlessly and Naturally in Removing any Unwanted Tattoos in 2 to 8 Weeks, Guaranteed

Monday, November 30, 2015

The Holistic Clinical Trials and Studies of Polycystic Ovarian Syndrome: The Stress Response and Management herbal Rhodiola (Rhodiola rosea)

By Kyle J. Norton
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.


                    Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cance(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women.
Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).


  The prevention and management In Herbal Medicine

                  The stress management herbal Medicine 

Stress in a natural reaction of human fight or fight response induced by pressure due to environmental condition or a stimulus. Long term stress can cause deleterious and cumulative effects on human body(1104), including emotional or cognitive problems, such as an increased risk of attentional deficit/hyperactivity, anxiety, and language delay(1103), especially for people with chronic illness, including women with Polycystic Ovarian Syndrome (PCOs)(1105).

                                       Rhodiola (Rhodiola rosea)

Rhodiola Rosea, one of the perennial plant grows in coldest region in the world, including the Arctic, is a genus Rhodiola, belongings to the family Crassulaceae, used in traditional medicine as an antiaging(1167) agent, and to treat fatigue(1168)(1169), depression(1170)(1171), anemia(1172), impotence(1173), inflammation(1174), infections(1175), nervous system disorders(1176)(1177), enhance physical endurance(1178), and increase an organism's resistance to stress(1167)(1179).etc.

Phytochemicals(1165)(1166)
1 .Salidroside
2. Sosavin
3. Rosin
4. Sosarin
5. Tyrosol
6. Lignan major compounds in the
7. Heterodontoside,
8. Viridoside
9. Mongrhoside
10. Cyanogenic glucoside rhodiocyanoside A
11. Epigallocatechin and gallate
12 . Epiga
13. Etc.

In an evaluating anti-stress effects, rhodiola rosea, exhibited positive effects on mental and physical performance under stress(1180)(1181), improved attention and cognitive function associated with its antidepressant activity(1180)(1182) and stress-protective effect of adaptogen(1181), through regulation of nitric oxide (NO) and cortisol levels(1180)(1181).
According to Gesundheitsbezirk Bozen,, rhodiola rosea active substance phenylpropanoide also processed sedative, anti-depressive(1180) and stress-modulated properties through stimulating the distribution of dopamine and serotonin(1182).
In animal model, the herb showed to display antidepressant(1181)(1182)(1184), adaptogenic(1181)(1184), anxiolytic(1184)(1186), nociceptive(1183)(1185) and locomotor activities(1186) induced by intense physical and psychological stress(1183).
In oxidative stress induced animal models, rhodiola is effective in the empowerment of performance(1187), modulation of the immune system(1187) against oxidative damage(1187).
Salidroside (SAL), an active component of Rhodiola rosea protect endothelium(1189) against H2O2-induced endothelial dysfunction(1188)(1189) and oxidative-stress-associated cardiovascular dysfunction(1189) through preventing the overactivation of oxidative stress-related downstream signaling pathways(1188).

All Forms of Arthritis are Curable
You Can Eliminate Osteoarthritis
By addressing the Underlying Causes through Clinical Trials and Studies

Pregnancy Miracle
Reverse Infertility And Get Pregnant Naturally
Using Holistic Ancient Chinese Medicine
.

Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O1.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF1, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R1, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N1, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA1, Arduc A2, Tuna MM1, Karakılıc E1, Dagdelen I1, Tutuncu Y1, Berker D1, Guler S1.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO1.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO1, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK1, Katalenich B2, Nagireddy P3, Chabbra P4, Kuhadiya N5, Fonseca V1.(PubMed)
(14) Acne in hirsute women by Lumezi BG1, Pupovci HL1, Berisha VL1, Goçi AU2, Gerqari A3.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N1, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H1, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women WithPolycystic Ovary Syndrome. by Whigham LD1, Butz DE2, Dashti H3, Tonelli M3, Johnson LK1, Cook ME2, Porter WP4, Eghbalnia HR5, Markley JL6, Lindheim SR7, Schoeller DA8, Abbott DH9, Assadi-Porter FM10.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA1, Azizia MM1, Hardiman PJ2.(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M1, Kjaer SK2, Jensen A1, Munk C1, Mellemkjaer L3.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E1.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E1, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(827a) Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management by Farshchi H, Rane A, Love A, Kennedy RL(PubMed)
(828) The optimal diet for women with polycystic ovary syndrome? by Marsh K, Brand-Miller J.(PubMed) (1106) Simultaneous Estimation of Withaferin A and Z-Guggulsterone in Marketed Formulation by RP-HPLC by Agrawal P1, Vegda R2, Laddha K2.(PubMed)
(1165) Phylogenetic and Phytochemical Characteristics of Plant Species with Adaptogenic Properties by Robyn KLein. CHAPTER 6
(1166) Phytochemical characterization of an adaptogenic preparation from Rhodiola heterodonta by Grace MH1, Yousef GG, Kurmukov AG, Raskin I, Lila MA.(PubMed)
(1167) Rhodiola: a promising anti-aging Chinese herb. by Jafari M1, Felgner JS, Bussel II, Hutchili T, Khodayari B, Rose MR, Vince-Cruz C, Mueller LD.(PubMed)
(1168) Anti-Fatigue Effects of Fermented Rhodiola rosea Extract in Mice by Kang DZ1, Hong HD2, Kim KI3, Choi SY4.(PubMed)
(1169) Rhodiola rosea for mental and physical fatigue in nursing students: a randomized controlled trial by Punja S1, Shamseer L2, Olson K3, Vohra S4.(PubMed)
(1170) Rhodiola rosea versus sertraline for major depressive disorder: A randomized placebo-controlled trial by Mao JJ1, Xie SX2, Zee J2, Soeller I3, Li QS3, Rockwell K4, Amsterdam JD5.(PubMed)
(1171) Rhodiola rosea therapy for major depressive disorder: a study protocol for a randomized, double-blind, placebo- controlled trial by Mao JJ1, Li QS2, Soeller I2, Xie SX3, Amsterdam JD4.(PubMed)
(1172) [Effect of salidroside on bone marrow cell cycle and expression of apoptosis-related proteins in bone marrow cells of bone marrow depressed anemia mice]. [Article in Chinese] by Zhang XS1, Zhu BD, Hung XQ, Chen YF.(PubMed)
(1173) Panax ginseng, Rhodiola rosea and Schisandra chinensis by Chan SW1.(PubMed)
(1174) Rhodiola inhibits dengue virus multiplication by inducing innate immune response genes RIG-I, MDA5 and ISG in human monocytes by Diwaker D1, Mishra KP, Ganju L, Singh SB.(PubMed)
(1175) Sambucus nigra extracts inhibit infectious bronchitis virus at an early point during replication by Chen C, Zuckerman DM, Brantley S, Sharpe M, Childress K, Hoiczyk E, Pendleton AR1.(PubMed)
(1176) [Advance in studies on pharmacological effect of salidroside on nervous system diseases]. [Article in Chinese] by Xie H1, Zhu DH.(PubMed)
(1177) Protective effects of a Rhodiola crenulata extract and salidroside on hippocampal neurogenesis against streptozotocin-induced neural injury in the rat by Qu ZQ1, Zhou Y, Zeng YS, Lin YK, Li Y, Zhong ZQ, Chan WY.(PubMed)
(1178) The effects of an acute dose of Rhodiola rosea on endurance exercise performance by Noreen EE1, Buckley JG, Lewis SL, Brandauer J, Stuempfle KJ.(PubMed)
(1179) Effects of plant extracts on the reversal of glucose-induced impairment of stress-resistance in Caenorhabditis elegans by Fitzenberger E1, Deusing DJ, Wittkop A, Kler A, Kriesl E, Bonnländer B, Wenzel U.(PubMed)
(1180) The adaptogens rhodiola and schizandra modify the response to immobilization stress in rabbits by suppressing the increase of phosphorylated stress-activated protein kinase, nitric oxide and cortisol by Panossian A1, Hambardzumyan M, Hovhanissyan A, Wikman G.(PubMed)
(1182) [The interaction of Rhodiola rosea and antidepressants. A case report]. [Article in German] by Maniscalco I1, Toffol E, Giupponi G, Conca A.(PubMed)
(1183) Adaptogenic and central nervous system effects of single doses of 3% rosavin and 1% salidroside Rhodiola rosea L. extract in mice by Perfumi M1, Mattioli L.(PubMed)
(1184) Characterization of the anxiolytic activity of Nunavik Rhodiola rosea by Cayer C1, Ahmed F, Filion V, Saleem A, Cuerrier A, Allard M, Rochefort G, Merali Z, Arnason JT.(PubMed)
(1185) Synergistic interactions between the antinociceptive effect of Rhodiola rosea extract and B vitamins in the mouse formalin test by Montiel-Ruiz RM1, González-Trujano ME, Déciga-Campos M.(PubMed)
(1186) Pharmacological evaluation of Potentilla alba L. in mice: adaptogenic and central nervous system effects by Shikov AN1, Lazukina MA, Pozharitskaya ON, Makarova MN, Golubeva OV, Makarov VG, Djachuk GI.(PubMed)
(1187) Effects of herbal supplements on the immune system in relation to exercise by Megna M1, Amico AP, Cristella G, Saggini R, Jirillo E, Ranieri M.(PubMed)
(1188) Salidroside stimulates mitochondrial biogenesis and protects against H₂O₂-induced endothelial dysfunction by Xing S1, Yang X1, Li W1, Bian F1, Wu D1, Chi J1, Xu G1, Zhang Y1, Jin S1.(PubMed)
(1189) Salidroside improves homocysteine-induced endothelial dysfunction by reducing oxidative stress by Leung SB1, Zhang H, Lau CW, Huang Y, Lin Z.(PubMed)

Sunday, November 29, 2015

The Holistic Clinical Trials and Studies of Polycystic Ovarian Syndrome: The Stress Response and Management herbal Rhaponticum or Maral root

By Kyle J. Norton
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.


                    Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cance(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women.
Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).


  The prevention and management In Herbal Medicine

                  The stress management herbal Medicine 

Stress in a natural reaction of human fight or fight response induced by pressure due to environmental condition or a stimulus. Long term stress can cause deleterious and cumulative effects on human body(1104), including emotional or cognitive problems, such as an increased risk of attentional deficit/hyperactivity, anxiety, and language delay(1103), especially for people with chronic illness, including women with Polycystic Ovarian Syndrome (PCOs)(1105).



      The stress management herbs: Rhaponticum or Maral root 

Stress in a natural reaction of human fight or fight response induced by pressure due to such as an environmental condition or a stimulus. Long term stress can cause deleterious and cumulative effects on human body(1104), including emotional or cognitive problems, such as an increased risk of attentional deficit/hyperactivity, anxiety, and language delay(1103), especially for people with chronic illness, including women with Polycystic Ovarian Syndrome (PCOs)(1105).

Rhaponticum also known as Maral root, is an herbaceous perennial plant belongings the family Asteraceae, used in traditional Siberian, Russian and Chinese medicine as anti-depressant(1191)(1192), anti anxiety(1192), anti menopausal complaints(1192)(1193), antioxidant(1194)(1195), immunomodulatory(1194)(1195), anticancerogenic(1194)(1196)(1197), antimicrobial(1194)(1195)(1198)(1199) and adaptogen agent(1194) and to treat impotence(1194), enhance mental and physical performance(1194)(1200), support the nervous(1194)(1201) and cardiovascular system(1194)(1202)(1203), improve work capacity(1194), etc.


Phytochemicals(1190)
1. Rosavin
2. Rosin
3. Rosarin
4. Salidroside
5. Ecdysteroids
6. Flavonoids
7. Phenolic acids
8. Polyacetylenes,
9. Sesquiterpene lactones
10. Triterpenoid glycosides
11. Terpenes
12. Etc.


According to Russian Academy of Medical Sciences, therbal medicne also processed anti metabolic syndrome such as serum lipid profile, corticosterone and cytokine concentrations, glucose tolerance, systolic blood pressure, triacylglycerol accumulation and its induction of inflammation,stress, and hepatic steatosis in rat model(1004).
In in Wistar rats model, N-feruloylserotonins, isolated from the seeds ofLeuzea carthamoides (WILLD.) DC, showed effectively in selective stress-reducing effects against stress-sensitive, such as reduced anxiety in the high-pain(1005).
In AdMax formulas, containing Leuzea carthamoides Iljin, Rhodiola rosea L., Eleutherococcus senticosus Maxim, and from dry berries of Schizandra chinensis Baill, improve response to stimulus and stress, physical endurance and counteract fatigue accordiung to Genext Research, Inc.(1006)

All Forms of Arthritis are Curable
You Can Eliminate Osteoarthritis
By addressing the Underlying Causes through Clinical Trials and Studies

Pregnancy Miracle
Reverse Infertility And Get Pregnant Naturally
Using Holistic Ancient Chinese Medicine
.

Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months

References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O1.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF1, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R1, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N1, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA1, Arduc A2, Tuna MM1, Karakılıc E1, Dagdelen I1, Tutuncu Y1, Berker D1, Guler S1.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO1.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO1, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK1, Katalenich B2, Nagireddy P3, Chabbra P4, Kuhadiya N5, Fonseca V1.(PubMed)
(14) Acne in hirsute women by Lumezi BG1, Pupovci HL1, Berisha VL1, Goçi AU2, Gerqari A3.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N1, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H1, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women WithPolycystic Ovary Syndrome. by Whigham LD1, Butz DE2, Dashti H3, Tonelli M3, Johnson LK1, Cook ME2, Porter WP4, Eghbalnia HR5, Markley JL6, Lindheim SR7, Schoeller DA8, Abbott DH9, Assadi-Porter FM10.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA1, Azizia MM1, Hardiman PJ2.(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M1, Kjaer SK2, Jensen A1, Munk C1, Mellemkjaer L3.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E1.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E1, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(827a) Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management by Farshchi H, Rane A, Love A, Kennedy RL(PubMed)
(828) The optimal diet for women with polycystic ovary syndrome? by Marsh K, Brand-Miller J.(PubMed) (1106) Simultaneous Estimation of Withaferin A and Z-Guggulsterone in Marketed Formulation by RP-HPLC by Agrawal P1, Vegda R2, Laddha K2.(PubMed)
(1190) Review Chemistry and pharmacology of Rhaponticum carthamoides: A review Ladislav Kokoska a,*, Dagmar Janovska(Elsevier)
(1191) [The use of a decoction of the rhizome of Leuzea carthamoides for the treatment of alcoholics with depressive states].[Article in Russian] by Ibatov AN.(PubMed)
(1192) Long-term effects of the rhapontic rhubarb extract ERr 731® on estrogen-regulated targets in the uterus and on the bone in ovariectomized rats by Keiler AM1, Papke A, Kretzschmar G, Zierau O, Vollmer G.(PubMed)
(1193) Treatment of menopausal symptoms by an extract from the roots of rhapontic rhubarb: the role of estrogen receptors by Vollmer G1, Papke A, Zierau O.(PubMed)
(1194) Chemistry and pharmacology of Rhaponticum carthamoides: a review by Kokoska L1, Janovska D.(PubMed)
(1195) A study on the effect of ethanol extract of Radix rhapontici on erythrocyte immune function in rats by Yan X1, Zhao H, Guan Y, Song Y, Meng J.(PubMed)
(1196) Anticarcinogenic activity of alpha-difluoromethylornithine, ginseng, eleutherococcus, and leuzea on radiation-induced carcinogenesis in female rats by Bespalov VG1, Alexandrov VA, Semenov AL, Kovan'Ko EG, Ivanov SD.(PubMed)
(1197) Subtype-specific activation of estrogen receptors by a special extract of Rheum rhaponticum (ERr 731), its aglycones and structurally related compounds in U2OS human osteosarcoma cells by Möller F1, Zierau O, Jandausch A, Rettenberger R, Kaszkin-Bettag M, Vollmer G.(PubMed)
(1198) Antimycobacterial effect of extract and its components from Rheumrhaponticum by Smolarz HD1, Swatko-Ossor M, Ginalska G, Medyńska E.(PubMed)
(1199) Investigation of the antimicrobial activity of Rhaponticum(Rhaponticum carthamoides D.C. Iljin) and shrubby cinquefoil (Potentilla fruticosa L.).[Article in English, Lithuanian] by Jurkštienė V1, Pavilonis A, Garšvienė D, Juozulynas A, Samsonienė L, Daukšienė D, Jankauskienė K, Simonienė-Kazlauskienė G, Stankevičius E.(PubMed)
(1200) Evaluation of molecular chaperons Hsp72 and neuropeptide Y as characteristic markers of adaptogenic activity of plant extracts by Asea A1, Kaur P, Panossian A, Wikman KG.(PubMed)
(1201) [Cerebroprotector activity of Rhaponticum carthamoides extract in rats with brain ischemia].[Article in Russian] by Plotnikov MB, Logvinov SV, Pugachenko NV, Maslov MIu, Aliev OI, Vasil'ev AS, Suslov NI, Potapov AV.(PubMed)
(1202) [Lipid peroxide, membrane fluidity of smooth muscle cells and atherosclerosis].[Article in Chinese] by Lu YC1(PubMed)
(1203) [Cardioprotective and antiarrhythmic properties of preparations fromLeuzea carthamoides, Aralia mandshurica, and Eleutherococcus senticosus].[Article in Russian] by Maslov LN, Guzarova NV.(PubMed)

(1204) Effects of rhaponticum carthamoides versus glycyrrhiza glabra and punica granatum extracts on metabolic syndrome signs in rats by Dushkin M1, Khrapova M, Kovshik G, Chasovskikh M, Menshchikova E, Trufakin V, Shurlygina A, Vereschagin E.(PubMed)
(1205) The selective effect of N-feruloylserotonins isolated from Leuzeacarthamoides on nociception and anxiety in rats by Yamamotová A1, Pometlová M, Harmatha J, Rasková H, Rokyta R.(PubMed)
(1206) Influence of the plant extract complex "AdMax" on global gene expression levels in cultured human fibroblast(PubMed)

Saturday, November 28, 2015

The Holistic Clinical Trials and Studies of Polycystic Ovarian Syndrome: The Insulin resistance improvement and/or anti metabolic syndrome herb: Astragalus

By Kyle J. Norton
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.


                    Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cance(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women.
Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).


  The prevention and management In Herbal Medicine

The Insulin resistance improvement and/or antimetabolic syndrome herbs: Astragalus


Astragalus (Astragalus membranaceus)(1045)
Huang Qi or Bei Qi is also known as Astragalus root. The sweet herb has been used as diuretic agent and to lower blood pressure, increase blood pressure, lessens proteinuria, improve endurance, protect liver function, regulate blood sugar, etc. as it tonifies Qi, raises Yang, strengthens the Defensive-Qi and the Exterior, expels toxins, etc. by enhancing the functions of lung and spleen channels(1045).

Ingredients
1. Astragaloside I,
2. Astragaloside II,
3. Daucosterol,
3. Beta-sitosterol,
4. Palmitic acid
5. Astragalus saponin A,B,C
6. Astramenbrangenin
7. Kumatakenin,
8. Choline,
9. Betaine,
10. Folic acid
11. Calyxosin,
12. Formononetin,
13. Cycloastragenol,
14. Astragaloside III,IV
15. Antibacterial ingredient,
16. L-3-hydroxy-9-methoxpterocarpan
17. Etc.

Epidemiological studies showed that stragalus polysaccharides (APS) ameliorates insulin resistance(1046)(1047) (IR) in rat cells and to elucidate the associated mechanisms, including increasing adiponectin secretion and reducing IL-6 secretion(1046), decreasing myostatin expression(1047), improving beta cell function(1049), regulating insulin signaling in insulin-resistant skeletal muscle(1047)(1048). insulin resistance related mRNA expression(1049), etc.
In metabolic syndrome, including increased body weight(1050), mild hypertension(1050), hyper insulinemia(1050), hyper triglyceridemia(1050), impaired glucose tolerance(1050)(1053) and impaired endothelium-dependent vasorelaxation(1050)(1051)(1052), astragaloside IV, a major constituent found in astragalus showed effectively in ameliorating metabolic syndrome(1050)(1052), probably through its antioxidant(1051), inhibition of abnormal TNF-alpha-induced intracellular free Ca(2+) accumulation in endothelial cells(1052), decreasing the elevated expression and activity in the skeletal muscles(1053).

All Forms of Arthritis are Curable
You Can Eliminate Osteoarthritis
By addressing the Underlying Causes through Clinical Trials and Studies

Pregnancy Miracle
Reverse Infertility And Get Pregnant Naturally
Using Holistic Ancient Chinese Medicine
.
Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months

References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O1.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF1, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R1, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N1, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA1, Arduc A2, Tuna MM1, Karakılıc E1, Dagdelen I1, Tutuncu Y1, Berker D1, Guler S1.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO1.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO1, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK1, Katalenich B2, Nagireddy P3, Chabbra P4, Kuhadiya N5, Fonseca V1.(PubMed)
(14) Acne in hirsute women by Lumezi BG1, Pupovci HL1, Berisha VL1, Goçi AU2, Gerqari A3.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N1, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H1, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women WithPolycystic Ovary Syndrome. by Whigham LD1, Butz DE2, Dashti H3, Tonelli M3, Johnson LK1, Cook ME2, Porter WP4, Eghbalnia HR5, Markley JL6, Lindheim SR7, Schoeller DA8, Abbott DH9, Assadi-Porter FM10.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA1, Azizia MM1, Hardiman PJ2.(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M1, Kjaer SK2, Jensen A1, Munk C1, Mellemkjaer L3.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E1.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E1, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(827a) Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management by Farshchi H, Rane A, Love A, Kennedy RL(PubMed)
(828) The optimal diet for women with polycystic ovary syndrome? by Marsh K, Brand-Miller J.(PubMed)
(1045) Huang Qi(Complementary and Alternative Healing University)
(1046) Amelioration of insulin resistance in rat cells by Astragaluspolysaccharides and associated mechanisms by Liu H1, Bai J2, Weng X3, Wang T3, Li M1.(PubMed)
(1047) Astragalus polysaccharide suppresses skeletal muscle myostatin expression in diabetes: involvement of ROS-ERK and NF-κB pathways by Liu M1, Qin J2, Hao Y3, Liu M4, Luo J5, Luo T4, Wei L6.(PubMed)
(1048) Astragalus polysaccharide improves insulin sensitivity in KKAy mice: regulation of PKB/GLUT4 signaling in skeletal muscle by Liu M1, Wu K, Mao X, Wu Y, Ouyang J.(PubMed)
(1049) A refined-JinQi-JiangTang tablet ameliorates prediabetes by reducinginsulin resistance and improving beta cell function in mice by Gao LH1, Liu Q1, Liu SN1, Chen ZY1, Li CN1, Lei L1, Sun SJ1, Li LY1, Liu JL1, Shen ZF2.(PubMed)
(1050) [Effects of Astragalus membranaceus and Potentilla discolor mixture on insulin resistance and its related mRNA expressions in KKAy mice with type 2 diabetes].[Article in Chinese] by Zhang DM1, Lou LX, Wu AM, Lü XY, Hu ZJ, Zhang YH, Liu HF.(PubMed)
(1051) Astragaloside IV improves homocysteine-induced acute phase endothelial dysfunction via antioxidation by Qiu LH1, Xie XJ, Zhang BQ.(PubMed)
(1052) Effects of astragaloside IV on pathogenesis of metabolic syndrome in vitro by Xu ME1, Xiao SZ, Sun YH, Ou-Yang Y, Zheng XX.(PubMed)
(1053) Hypoglycemic effect of Astragalus polysaccharide and its effect on PTP1B by Wu Y1, Ou-Yang JP, Wu K, Wang Y, Zhou YF, Wen CY.(PubMed)

Friday, November 27, 2015

The Holistic Clinical Trials and Studies of Polycystic Ovarian Syndrome: The Stress Response and Management herbal Ginseng (Panax spp.)

By Kyle J. Norton
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.


                    Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cance(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women.
Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).


  The prevention and management In Herbal Medicine

                  The stress management herbal Medicine 

Stress in a natural reaction of human fight or fight response induced by pressure due to environmental condition or a stimulus. Long term stress can cause deleterious and cumulative effects on human body(1104), including emotional or cognitive problems, such as an increased risk of attentional deficit/hyperactivity, anxiety, and language delay(1103), especially for people with chronic illness, including women with Polycystic Ovarian Syndrome (PCOs)(1105).

Ginseng (Panax spp.)

(See Herbal treatment for PCOs for more information)
[ Ginseng Asia is also known as Panax ginseng. Since it has been grown in the cold places in the Asian, Asian ginseng is considered as yang promoting, according to traditional Chinese medicine.
Korean red ginseng extract (KRGE) in the experiment in PCOs induced rodent, improved PCO-related ovarian dysfunction(830). In rat model, induced by injection of estradiol valerate (EV), the extract also regulated sympathetic nerve activity by significantly lower expression of NGF protein (involved in the growth of peripheral nerve cells) and NGF mRNA(the form of RNA that carries information from DNA) involved in the abnormal process caused by steroid-induced PCO(830). Also, in the experiment of Ginseng total saponins (GTS) involved polycystic ovaries induced by a single intramuscular injection of 4 mg estradiol valerate (EV) in rats, GTS decreased the expression of NGF in ovary tissue(831)].

(See herbal medicine for weight loss)
[Ginseng is a slow-growing perennial plants with fleshy roots, the genus Panax, belonging to the family Araliaceae. Depending to the climate where it grows, ginseng can be classified mainly into Panax ginseng Asian ginseng (root), Red ginseng, wild ginseng, American ginseng (root)(791).
In 10 obese middle-aged Korean women who took Panax ginseng extracts for 8 wk, showed effectively in influence on gut microbiota in promoting weigh loss but depending to the composition of gut microbiota prior to ginsengintake(792). In mice fed on a high-fat diet, ginseng saponin and ginsenosides not only exerted anti-obesity effects via the modulation of physiological lipid metabolism in vivo or intracellular signalling in cell culture systems, but also promoted anti-obesity effects, through abnormal physiology via HFD. Leptin, insulin, and adiponectin, which carry out critical functions in energy and lipid metabolism(793)].

The Phytochemicals
1. Ginsenoside
2. Notoginsenoside
3. Chikusetsuaponin IV
4. Panaxynol
5. Ginsenyne
6. Alpha pansinsene
7. Beta pansinsene
8. Beta farnesene
9. Bicyclogermacrene
10. Beta elemene
11. Gama elemene
12. Alpha neodovene
13. Beta neodovene
14. Alpha humulene
15. Beta humulene
16. Caryophyllene
17. Beta gurjunene
18. Alpha gurjunene
19. Citric acid
20. Isocitric acid
21. Fumaric acid
22. Oleic acid,
23. Linoleic acid
24. Beta sitosterol
25. Stigmasterol
26. Daucosterol
27. Sitosteryl-o-(6-O-fatty acyl)-glucpyranoside
28. Etc.

Panax ginseng, native to Korea, one of most frequent and wonderful used over thousand years in herbal medicine for improvement of male over all health due to aging diminished steroidal hormone in Asian(1138) has found to process significant anti-stress (1137)(1143)(1144), such as adapt to stress(1138) through reverted cholesterol (CL), creatine kinase (CK) activity(1137) anti oxidative stress(1139)(1142)(1146) through its elevation in catalase (CAT), and superoxide dismutase (SOD) activities as scavenger enzymes(1139). antioxidant effects(1140).
In immobilized mice, orally administered ginsenoside Rb1 found in Panax ginseng exhibited its anti stress effects through regulation of serum levels of corticosterone(1145) and interleukin (IL)-6(1141).
In chronic unpredictable mild stress rat model, ginsenosides also ameliorated stress symptoms of depression(1147)(1149)(1150) through significantly suppressed behavioral and biochemical changes(1147) and cognitive impairment, neuroinflammation, and biochemical alterations through improved corticosterone levels; and attenuated oxidative-nitrergic stress(1148).
In stress induced metabolic syndrome(1151), ginseng' saponins (ginsenosides) are proven effectively for its properties of anti-hyperglycemia, insulin sensitization, islet protection, anti-obesity and anti-oxidation in many model systems, according to Louisana State University System(1152).


All Forms of Arthritis are Curable
You Can Eliminate Osteoarthritis
By addressing the Underlying Causes through Clinical Trials and Studies

Pregnancy Miracle
Reverse Infertility And Get Pregnant Naturally
Using Holistic Ancient Chinese Medicine
.

Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O1.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF1, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R1, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N1, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA1, Arduc A2, Tuna MM1, Karakılıc E1, Dagdelen I1, Tutuncu Y1, Berker D1, Guler S1.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO1.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO1, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK1, Katalenich B2, Nagireddy P3, Chabbra P4, Kuhadiya N5, Fonseca V1.(PubMed)
(14) Acne in hirsute women by Lumezi BG1, Pupovci HL1, Berisha VL1, Goçi AU2, Gerqari A3.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N1, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H1, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women WithPolycystic Ovary Syndrome. by Whigham LD1, Butz DE2, Dashti H3, Tonelli M3, Johnson LK1, Cook ME2, Porter WP4, Eghbalnia HR5, Markley JL6, Lindheim SR7, Schoeller DA8, Abbott DH9, Assadi-Porter FM10.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA1, Azizia MM1, Hardiman PJ2.(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M1, Kjaer SK2, Jensen A1, Munk C1, Mellemkjaer L3.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E1.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E1, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(827a) Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management by Farshchi H, Rane A, Love A, Kennedy RL(PubMed)
(828) The optimal diet for women with polycystic ovary syndrome? by Marsh K, Brand-Miller J.(PubMed) (1106) Simultaneous Estimation of Withaferin A and Z-Guggulsterone in Marketed Formulation by RP-HPLC by Agrawal P1, Vegda R2, Laddha K2.(PubMed)
(1103) Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? by Talge NM1, Neal C, Glover V; EarlyStress, Translational Research and Prevention Science Network: Fetal and Neonatal Experience on Child and Adolescent Mental Health.(PubMed)
(1104) Immediate and long-term effects of meditation on acute stressreactivity, cognitive functions, and intelligence by Singh Y1, Sharma R, Talwar A.(PubMed)
(1105) The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage by Hart R1, Doherty DA.(PubMed)
(1137) Anti-stress effects of Ginkgo biloba and Panax ginseng: a comparative study by Rai D1, Bhatia G, Sen T, Palit G.(PubMed)
(1138) Ginseng, Korean(The free dictionary by Farlet)
(1139) Effects of Panax ginseng extract on exercise-induced oxidative stressby Kim SH1, Park KS, Chang MJ, Sung JH.(PubMed)
(1140) Saponins from Panax japonicus attenuate D-galactose-induced cognitive impairment through its anti-oxidative and anti-apoptotic effects in rats by Wang T1, Di G, Yang L, Dun Y, Sun Z, Wan J, Peng B, Liu C, Xiong G, Zhang C, Yuan D. (PubMed)
(1141) Anti-stress effects of 20(S)-protopanaxadiol and 20(S)-protopanaxatriol in immobilized mice by Oh HA1, Kim DE, Choi HJ, Kim NJ, Kim DH.(PubMed)
(1142) Protective effect of panax notoginseng saponins on acute ethanol-induced liver injury is associated with ameliorating hepatic lipid accumulation and reducing ethanol-mediated oxidative stress by Ding RB1, Tian K, Cao YW, Bao JL, Wang M, He C, Hu Y, Su H, Wan JB.(PubMed)
(1143) [The anti-stress effect of saponins extracted from panax ginseng fruit and the hypophyseal-adrenal system (author's transl)].[Article in Chinese] by Zhang SC, Jiang XL.(PubMed)
(1144) Ginseng and the hypothalamic-pituitary control of stress by Fulder SJ.(PubMed)
(1145) Stimulation of pituitary-adrenocortical system by ginseng saponin by Hiai S, Yokoyama H, Oura H, Yano S.(PubMed)
(1146) [Study on the mechanism of action of total saponins of Panaxnotoginseng in ameliorating oxidative stress and insulin resistance in rats fed with high fat diet].[Article in Chinese] by Zhang SS1, Wu ZY2, Chen JM3, Guo QK2, Li L2, Wang ZF2, Gao Y4, Ma ZC4.(PubMed)
(1147) [Effects of ginsenosides on hypothalamic-pituitary-adrenal function and brain-derived neurotrophic factor in rats exposed to chronic unpredictable mild stress].[Article in Chinese] by Liu L1, Luo Y, Zhang R, Guo J.(PubMed)
(1148) Modulation of nitrergic signalling pathway by American ginsengattenuates chronic unpredictable stress-induced cognitive impairment, neuroinflammation, and biochemical alterations by Rinwa P1, Kumar A.(PubMed)
(1149) Ginsenoside Rb3 exerts antidepressant-like effects in several animal models by Cui J1, Jiang L, Xiang H.(PubMed)
(1150) Antidepressant effects of ginseng total saponins in the forced swimming test and chronic mild stress models of depression by Dang H1, Chen Y, Liu X, Wang Q, Wang L, Jia W, Wang Y.(PubMed)
(1151) Role of Endoplasmic Reticulum Stress in Metabolic Disease and Other Disorders by Lale Ozcan and Ira Tabas(PubMed)
(1152) Traditional chinese medicine in treatment of metabolic syndrome by Yin J1, Zhang H, Ye J.(PubMed)

Thursday, November 26, 2015

The Holistic Clinical Trials and Studies of Polycystic Ovarian Syndrome: The Stress Response and Management herbal Ashwagandha

By Kyle J. Norton
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.


                    Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cance(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women.
Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).


  The prevention and management In Herbal Medicine

                  The stress management herbal Medicine 

Stress in a natural reaction of human fight or fight response induced by pressure due to environmental condition or a stimulus. Long term stress can cause deleterious and cumulative effects on human body(1104), including emotional or cognitive problems, such as an increased risk of attentional deficit/hyperactivity, anxiety, and language delay(1103), especially for people with chronic illness, including women with Polycystic Ovarian Syndrome (PCOs)(1105).


Ashwagandha (Withania somnifera)


Ashwagandha(Withania somnifera), also known as Indian Ginseng is a nightshade plant belongings to the family Solanaceae, native to India, northern Africa, and the Middle East, used in Ayurvedic medicine over 3000 years(1101) as antitumors(1107)(1108), anti ulcers(1111), anti-stress(1112)(1115)(1118), improved cognition dysfunction(1109)(1110)(1118), anti-inflammatory(1113)(1116), antioxidant(1114)(1117), promoted immunity(1120)(1121), anti-aging(1119), etc., herbal medicine.

Phytochemicals(1102)
1. Isopelletierine
2. Anaferine
3. Cuseohygrine
4. Anahygrine
5. Withanolides
6. Withaferins
7. Saponins
8. Sitoindosides
9. Acylsterylglucosides
10. Z-Guggulsterone(1106)

11. Etc.

Epidemiologically strong evidences suggested that herbal ashwagandha processes anti stress related disorders( induced by oxidative stress(1122)(1123) and long term stress(1123) effects, probably through its antioxidant(1123)(1124)(1126)(1114)(1117), anti-stress(1112)(1115)(1118), anti-inflammatory(1113)(1116), immunomoduratory(1120)(1121) effects. In rat model, hydroalcoholic extract exerted its antioxidant effect against psychological symptoms(1132) induced by long term stress, such as reduced motor performance(1124), cognitive impairment(1125)(1126, anxiety(1127)(1128), sleep disorder(1129)(1130), depression(1131), etc. In stress induced by phyisological symptoms, the herb has showen to reduce fatigue(1133) risk of hypertension(1134), risk of stroke(1135). risk of diabetes(1136), improve energy(1132), etc.

All Forms of Arthritis are Curable
You Can Eliminate Osteoarthritis
By addressing the Underlying Causes through Clinical Trials and Studies

Pregnancy Miracle
Reverse Infertility And Get Pregnant Naturally
Using Holistic Ancient Chinese Medicine
.

Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months
References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O1.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF1, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R1, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N1, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA1, Arduc A2, Tuna MM1, Karakılıc E1, Dagdelen I1, Tutuncu Y1, Berker D1, Guler S1.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO1.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO1, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK1, Katalenich B2, Nagireddy P3, Chabbra P4, Kuhadiya N5, Fonseca V1.(PubMed)
(14) Acne in hirsute women by Lumezi BG1, Pupovci HL1, Berisha VL1, Goçi AU2, Gerqari A3.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N1, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H1, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women WithPolycystic Ovary Syndrome. by Whigham LD1, Butz DE2, Dashti H3, Tonelli M3, Johnson LK1, Cook ME2, Porter WP4, Eghbalnia HR5, Markley JL6, Lindheim SR7, Schoeller DA8, Abbott DH9, Assadi-Porter FM10.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA1, Azizia MM1, Hardiman PJ2.(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M1, Kjaer SK2, Jensen A1, Munk C1, Mellemkjaer L3.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E1.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E1, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(827a) Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management by Farshchi H, Rane A, Love A, Kennedy RL(PubMed)
(828) The optimal diet for women with polycystic ovary syndrome? by Marsh K, Brand-Miller J.(PubMed) (1106) Simultaneous Estimation of Withaferin A and Z-Guggulsterone in Marketed Formulation by RP-HPLC by Agrawal P1, Vegda R2, Laddha K2.(PubMed)
(1101) Steroidal lactones from Withania somnifera, an ancient plant for novel medicine by Mirjalili MH, Moyano E, Bonfill M, Cusido RM, Palazón J.(PubMed)
(1102) An Overview on Ashwagandha: A Rasayana (Rejuvenator) of Ayurveda by Narendra Singh, Mohit Bhalla, Prashanti de Jager, and Marilena Gilca(PubMed)
(1103) Antenatal maternal stress and long-term effects on child neurodevelopment: how and why? by Talge NM1, Neal C, Glover V; EarlyStress, Translational Research and Prevention Science Network: Fetal and Neonatal Experience on Child and Adolescent Mental Health.(PubMed)
(1104) Immediate and long-term effects of meditation on acute stressreactivity, cognitive functions, and intelligence by Singh Y1, Sharma R, Talwar A.(PubMed)
(1105) The potential implications of a PCOS diagnosis on a woman's long-term health using data linkage by Hart R1, Doherty DA.(PubMed)
(1106) Simultaneous Estimation of Withaferin A and Z-Guggulsterone in Marketed Formulation by RP-HPLC by Agrawal P1, Vegda R2, Laddha K2.(PubMed)
(1107) Selective killing of cancer cells by leaf extract of Ashwagandha: components, activity and pathway analyses by Widodo N1, Takagi Y, Shrestha BG, Ishii T, Kaul SC, Wadhwa R.(PubMed)
(1108) Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect by Widodo N1, Kaur K, Shrestha BG, Takagi Y, Ishii T, Wadhwa R, Kaul SC.(PubMed)
(1109) Effect of standardized aqueous extract of Withania somnifera on tests of cognitive and psychomotor performance in healthy human participants by Pingali U1, Pilli R1, Fatima N1.(PubMed)
(1110) Randomized placebo-controlled adjunctive study of an extract ofwithania somnifera for cognitive dysfunction in bipolar disorder by Chengappa KN1, Bowie CR, Schlicht PJ, Fleet D, Brar JS, Jindal R.(PubMed)
(1111) Evaluation of the anti-ulcer activity of NR-ANX-C (a polyherbal formulation) in aspirin & pyloric ligature induced gastric ulcers in albino rats by Nair V1, Arjuman A, Gopalakrishna HN, Dorababu P, Mirshad PV, Bhargavan D, Chatterji D.(PubMed)
(1112) Effect of Withania somnifera (Ashwagandha) root extract on amelioration of oxidative stress and autoantibodies production in collagen-induced arthritic rats by Khan MA, Subramaneyaan M, Arora VK, Banerjee BD, Ahmed RS.(PubMed)
(1113) Evaluation of anti-inflammatory effect of Withania somnifera root on collagen-induced arthritis in rats by Gupta A1, Singh S.(PubMed)
(1114) Protective effect of Withania somnifera root powder in relation to lipid peroxidation, antioxidant status, glycoproteins and bone collagen on adjuvant-induced arthritis in rats by Rasool M1, Varalakshmi P.(PubMed)
(1115) Withania somnifera Improves Semen Quality in Stress-Related Male Fertility by Mahdi AA1, Shukla KK, Ahmad MK, Rajender S, Shankhwar SN, Singh V, Dalela D.(PubMed)
(1116) Withaferin A inhibits pro-inflammatory cytokine-induced damage to islets in culture and following transplantation by SoRelle JA1, Itoh T, Peng H, Kanak MA, Sugimoto K, Matsumoto S, Levy MF, Lawrence MC, Naziruddin B.(PubMed)
(1117) Evaluation of antioxidant potential of Rasayana drugs in healthy human volunteers by Kuchewar VV1, Borkar MA2, Nisargandha MA3.(PubMed)
(1118) Withania somnifera (Ashwagandha) in neurobehavioural disorders induced by brain oxidative stress in rodents: a systematic review and meta-analysis by Durg S1, Dhadde SB, Vandal R, Shivakumar BS, Charan CS.(PubMed)
(1119) In vitro protective effects of Withania somnifera (L.) dunal root extract against hydrogen peroxide and β-amyloid(1-42)-induced cytotoxicity in differentiated PC12 cells by Kumar S1, Seal CJ, Howes MJ, Kite GC, Okello EJ.(PubMed)
(1120) Chemotypical variations in Withania somnifera lead to differentially modulated immune response in BALB/c mice by Kushwaha S1, Roy S, Maity R, Mallick A, Soni VK, Singh PK, Chaurasiya ND, Sangwan RS, Misra-Bhattacharya S, Mandal C.(PubMed)
(1121) Molecular insight into the immune up-regulatory properties of the leaf extract of Ashwagandha and identification of Th1 immunostimulatory chemical entity by Khan S1, Malik F, Suri KA, Singh J.(PubMed)
(1122) Evaluation of the anti-proliferative and anti-oxidative activities of leaf extract from in vivo and in vitro raised Ashwagandha by Kaur K1, Rani G, Widodo N, Nagpal A, Taira K, Kaul SC, Wadhwa R.(PubMed)
(1123) Anti-oxidant effect of Withania somnifera glycowithanolides in chronic footshock stress-induced perturbations of oxidative free radical scavenging enzymes and lipid peroxidation in rat frontal cortex and striatum by Bhattacharya A1, Ghosal S, Bhattacharya SK.(PubMed)
(1124) Evaluation of Withania somnifera in a middle cerebral artery occlusion model of stroke in rats by Chaudhary G1, Sharma U, Jagannathan NR, Gupta YK.(PubMed)
(1125) Propoxur-induced acetylcholine esterase inhibition and impairment of cognitive function: attenuation by Withania somnifera by Yadav CS1, Kumar V, Suke SG, Ahmed RS, Mediratta PK, Banerjee BD.(PubMed)
(1126) Attenuation of oxidative damage-associated cognitive decline byWithania somnifera in rat model of streptozotocin-induced cognitiveimpairment by Ahmed ME1, Javed H, Khan MM, Vaibhav K, Ahmad A, Khan A, Tabassum R, Islam F, Safhi MM, Islam F.(PubMed)
(1127) An alternative treatment for anxiety: a systematic review of human trial results reported for the Ayurvedic herb ashwagandha (Withaniasomnifera) by Pratte MA1, Nanavati KB, Young V, Morley CP.(PubMed)
(1128) Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence by Sarris J1, McIntyre E, Camfield DA.(PubMed)
(1129) Effect of Withania somnifera on Sleep-Wake Cycle in Sleep-Disturbed Rats: Possible GABAergic Mechanism by Kumar A1, Kalonia H.(PubMed)
(1130) Protective effect of Withania somnifera Dunal on the behavioral and biochemical alterations in sleep-disturbed mice (Grid over water suspended method) by Kumar A1, Kalonia H.(PubMed)
(1131) Protective effect of Withania somnifera dunal root extract against protracted social isolation induced behavior in rats by Gupta GL1, Rana AC.(PubMed)
(1132) An overview on ashwagandha: a Rasayana (rejuvenator) of Ayurveda by Singh N1, Bhalla M, de Jager P, Gilca M.(PubMed)
(1133) Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients by Biswal BM1, Sulaiman SA, Ismail HC, Zakaria H, Musa KI.(PubMed)
(1134) Withania somnifera shows a protective effect in monocrotaline-induced pulmonary hypertension by Kaur G1, Singh N, Samuel SS, Bora HK, Sharma S, Pachauri SD, Dwivedi AK, Siddiqui HH, Hanif K.(PubMed)
(1135) Withania somnifera Improves Ischemic Stroke Outcomes by Attenuating PARP1-AIF-Mediated Caspase-Independent Apoptosis by Raghavan A1, Shah ZA.(PubMed)
(1136) The aqueous extract of Withania coagulans fruit partially reverses nicotinamide/streptozotocin-induced diabetes mellitus in rats by Shukla K1, Dikshit P, Shukla R, Gambhir JK.(PubMed)

Wednesday, November 25, 2015

The Holistic Clinical Trials and Studies of Polycystic Ovarian Syndrome: The Insulin resistance improvement and/or anti metabolic syndrome herbal Cinnamon

By Kyle J. Norton
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.


                    Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cance(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women.
Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).


  The prevention and management In Herbal Medicine



The Insulin resistance improvement and/or antimetabolic syndrome herbs: Cinnamon(1086)


Cinnamon is a spice derived from the inner bark of tree, native to South East Asia, of over 300 species of the genus Cinnamomum, belongings to the family Lauraceae used in herbal and traditional medicine as anti-microbial agent(1087) and to improve reproductive organs(1088), prevent flatulence(1089) and menstrual cramping(1087), treat gastrointestinal complaints(1089), diarrhea(1087), bad breath(1090), headache(1087), etc.(1086)(1087).

Ingredients(1087)
1. Cinnamic aldehyde
2.Cinnamyl acetate
3. Eugenol
4. Aldehyde
5. Pinene
6. Coumarins
7. Cinnzeylanol
8. Cinnzeylanine
9. Safrol
10. Methylhydroxy chalcone polymer (MHCP)

Epidemiological studies suggested that cinnamon cocsist a sgnificant anti insulin resistance(1091)(1092)(1094) and anti metabolic syndrome(1093)(1094)(1095)(1096)(1097) properties, such as lowering total cholesterol(1093), low-density lipoprotein cholesterol(1093) and improving high-density lipoprotein cholesterol(1093), may be due to its antihyperglycaemic (1091)(1093) and potential to reduce postprandial blood glucose levels(1091)(1092), liver fat(1098) and and improved glucose homeostasis(1098) properties, by regulating the mechanisms of-medicated glucose and lipid metabolism(1099), such as decreased the mRNA expression of inflammatory cytokine(TNF-alpha) in adipose tissue(1100) and upregulated mRNA expression of insulin-regulated membrane trafficking(1100) and whole body glucose homeostasi(GLUT-4) in skeletal muscle(1100).

All Forms of  Arthritis are Curable
You Can Eliminate Osteoarthritis
By addressing the Underlying Causes through Clinical Trials and Studies

Pregnancy Miracle
Reverse Infertility And Get Pregnant Naturally
Using Holistic Ancient Chinese Medicine
.

Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months

References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O1.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF1, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R1, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N1, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA1, Arduc A2, Tuna MM1, Karakılıc E1, Dagdelen I1, Tutuncu Y1, Berker D1, Guler S1.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO1.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO1, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK1, Katalenich B2, Nagireddy P3, Chabbra P4, Kuhadiya N5, Fonseca V1.(PubMed)
(14) Acne in hirsute women by Lumezi BG1, Pupovci HL1, Berisha VL1, Goçi AU2, Gerqari A3.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N1, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H1, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women WithPolycystic Ovary Syndrome. by Whigham LD1, Butz DE2, Dashti H3, Tonelli M3, Johnson LK1, Cook ME2, Porter WP4, Eghbalnia HR5, Markley JL6, Lindheim SR7, Schoeller DA8, Abbott DH9, Assadi-Porter FM10.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA1, Azizia MM1, Hardiman PJ2.(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M1, Kjaer SK2, Jensen A1, Munk C1, Mellemkjaer L3.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E1.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E1, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(827a) Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management by Farshchi H, Rane A, Love A, Kennedy RL(PubMed)
(828) The optimal diet for women with polycystic ovary syndrome? by Marsh K, Brand-Miller J.(PubMed)
(1086) Popular Herbs -Cinnamonby Kyle J. Norton
(1087) Rou Gui(Complementary and Alternative Healing University)
(1088) Herbal Cinnamon and Infertility by Kyle J. Norton
(1089) Anti-inflammatory effect of cinnamaldehyde in Helicobacter pylori induced gastric inflammation by Muhammad JS1, Zaidi SF, Shaharyar S, Refaat A, Usmanghani K, Saiki I, Sugiyama T.(PubMed)
(1 090) Short-term germ-killing effect of sugar-sweetened cinnamon chewing gum on salivary anaerobes associated with halitosis by Zhu M1, Carvalho R, Scher A, Wu CD.(PubMed)
(1091) The potential of cinnamon to reduce blood glucose levels in patients with type 2 diabetes and insulin resistance by Kirkham S1, Akilen R, Sharma S, Tsiami A.(PubMed)
(1092) Cinnamon supplementation in patients with type 2 diabetes mellitus by Pham AQ1, Kourlas H, Pham DQ.(PubMed)
(1093)Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes by Lu T1, Sheng H, Wu J, Cheng Y, Zhu J, Chen Y.(PubMed)
(1094) Turmeric improves post-prandial working memory in pre-diabetes independent of insulin by Lee MS1, Wahlqvist ML, Chou YC, Fang WH, Lee JT, Kuan JC, Liu HY, Lu TM, Xiu L, Hsu CC, Andrews ZB, Pan WH.(PubMed)
(1095) Cinnamon: potential role in the prevention of insulin resistance,metabolic syndrome, and type 2 diabetes by Qin B1, Panickar KS, Anderson RA.(PubMed)
(1096) Alternative and complementary treatments for metabolic syndrome by Power M1, Pratley R.(PubMed)
(1097) Cinnamon improves insulin sensitivity and alters the body composition in an animal model of the metabolic syndrome by Couturier K1, Batandier C, Awada M, Hininger-Favier I, Canini F, Anderson RA, Leverve X, Roussel AM.(PubMed)
(1098) Cinnamon extract improves insulin sensitivity in the brain and lowers liver fat in mouse models of obesity by Sartorius T1, Peter A2, Schulz N3, Drescher A2, Bergheim I4, Machann J5, Schick F6, Siegel-Axel D2, Schürmann A3, Weigert C1, Häring HU1, Hennige AM7.(PubMed)
(1099) Antihyperglycemic and antihyperlipidemic action of Cinnamomi Cassiae (Cinnamon bark) extract in C57BL/Ks db/db mice by Kim SH1, Choung SY.(PubMed)
(1100) Antihyperglycemic and antihyperlipidemic action of cinnamaldehyde in C57BLKS/J db/db mice by Li J1, Liu T, Wang L, Guo X, Xu T, Wu L, Qin L, Sun W.(PubMed)

Tuesday, November 24, 2015

The Holistic Clinical Trials and Studies of Polycystic Ovarian Syndrome: The Insulin resistance improvement and/or anti metabolic syndrome herb: Green Tea

By Kyle J. Norton
Health article writer and researcher; Over 10.000 articles and research papers have been written and published on line, including world wide health, ezine articles, article base, healthblogs, selfgrowth, best before it's news, the karate GB daily, etc.,.
Named TOP 50 MEDICAL ESSAYS FOR ARTISTS & AUTHORS TO READ by Disilgold.com Named 50 of the best health Tweeters Canada - Huffington Post
Nominated for shorty award over last 4 years
Some articles have been used as references in medical research, such as international journal Pharma and Bio science, ISSN 0975-6299.


                    Polycystic Ovarian Syndrome

Polycystic Ovarian Syndrome is defined as endocrinologic diseases among reproductive-age women caused by undeveloped follicles clumping on the ovaries that interferes with the function of the normal ovaries associated with a high risk for metabolic disorder(1) as resulting of enlarged ovaries(2), leading to hormone imbalance(excessive androgen and anti-müllerian hormone (AMH) )(1)(3)(4)(5), induced Hirsutism(6)(7), reproductive disorder(10(12)), risks of type 2 diabetes(9)(10)(11), metabolic syndrome(10)(12) and early cardiovasular disease(8)(13), acne(10)(14), endometrial cance(18)(19),weight gain and obesity(15)(16)(17). The syndrome effects over 5% of women population or 1 in 20 women.
Unfortunately, according to studies, women with PCOs after the reproductive age, are associated to continuously increase risk of type II diabetes, with no increasing altered glucose tolerance(20), CVD and hypertension(21).


  The prevention and management In Herbal Medicine

The Insulin resistance improvement and/or anti metabolic syndrome herbs: Green Tea(1065)

Green tea contains more amount of antioxidants than any drinks or food with the same volume, and is the leaves of Camellia sinensis, undergone minimal oxidation during processing, originated from China. Green tea has been a precious drink in traditional Chinese culture and used exceptional in socialization for more than 4000 thousand years. Because of their health benefits, they have been cultivated for commercial purposes all over the world(1065).

Ingredients
1. Epigallocatechin gallate
2. Flavonoids
3. Tannins
4. Caffeine
5. Polyphenols
6. Boheic acid
7. Theophylline
8. Theobromine
9. Anthocyanins
10. Gallic acid
11. Etc.

Epidemiological studies, linking green tea in reduced risk of prevented the development of insulin resistance(1066)(1067) and metabolic sundrome such as obesity(1068)(1069)(1073), hypertension(1070)(1071) hypercholesterolemia and hyperglycemia(1072)(1073), diabetes(1074)(1075)... have produced some statistic results.
In inslunin resistances, epigallocatechin gallate (EGCG), the major chemical constituents of green tea effectively modulate of insulin productionb throughinhibited insulin-stimulated glucose uptake(1076)(1078)(1077) via some mechnisms, including attenuated inflammatory cytokine levels(1076), inhibition of the GLUT4(the insulin-regulated glucose transporter found primarily in adipose tissues and striated muscle (skeletal and cardiac).)translocation(1077), AMPK pathways(an enzyme that plays a role in cellular energy homeostasis)(1078)....
In metabolic synfrome, green tea extract, polyphenol epigallocatechin gallatesignificantly controled abnormalities linked to metabolic syndrome (MS)(1079)(1080)(1083)(1084)(1085) through influence the maintenance of weight loss(1079)(1082)(1084), high-density lipoprotein-cholesterol(1079), triglycerides(1079), and glucose concentrations(1079)(1080), counteracted endothelial dysfunction(1080)(1081) and ameliorated metabolic insulin resistance(1080) in skeletal muscle and liver(1080).

Ovarian Cysts And PCOS Elimination
Holistic System In Existence That Will Show You How To
Permanently Eliminate All Types of Ovarian Cysts Within 2 Months

References
(1) Adiposity and metabolic dysfunction in polycystic ovary syndrome by Sam S.(PubMed)
(2) A "kiss" before conception: triggering ovulation with kisspeptin-54 may improve IVF by Young SL.(PubMed)
(3.) Androgen hyperfunction and excessive heterosexual hair growth in women, with special attention to the polycystic ovarian syndrome by Lunde O1.(PubMed)
(4) Expression of anti-Müllerian hormone in letrozole rat model of polycystic ovary syndrome by Du DF1, Li XL, Fang F, Du MR.(PubMed)
(5) [Serum levels of anti-muller hormone in women with polycystic ovary syndrome and healthy women of reproductive age].[Article in Bulgarian] by Parahuleva N, Pehlivanov B, Orbecova M, Deneva T, Uchikova E.(PubMed)
(6) [Current opinions on the etiology and pathophysiology of hirsutism].[Article in Polish] by Krysiak R1, Kedzia A, Okopień B.(PubMed)
(7) The clinical evaluation of hirsutism by Somani N1, Harrison S, Bergfeld WF.(PubMed)
(8) Polycystic ovary syndrome and insulin: our understanding in the past, present and future by Mayer SB1, Evans WS, Nestler JE.(PubMed)
(9) Association of mean platelet volume with androgens and insulin resistance in nonobese patients with polycystic ovary syndrome by Dogan BA1, Arduc A2, Tuna MM1, Karakılıc E1, Dagdelen I1, Tutuncu Y1, Berker D1, Guler S1.(PubMed)
(10) Approach to the patient: contraception in women with polycystic ovary syndrome by Yildiz BO1.(PubMed)
(11) Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women by Talbott EO1, Zborowski JV, Rager JR, Kip KE, Xu X, Orchard TJ.(PubMed)
(12) Prevalence of vitamin D deficiency in Slovak women with polycystic ovary syndrome and its relation to metabolic and reproductive abnormalities by Figurová J1, Dravecká I, Javorský M, Petríková J, Lazúrová I.(PubMed)
(13) Role of Insulin Sensitizers on Cardiovascular Risk Factors in Polycystic Ovarian Syndrome: A Meta-Analysis by Thethi TK1, Katalenich B2, Nagireddy P3, Chabbra P4, Kuhadiya N5, Fonseca V1.(PubMed)
(14) Acne in hirsute women by Lumezi BG1, Pupovci HL1, Berisha VL1, Goçi AU2, Gerqari A3.(PubMed)
(15) Obesity and polycystic ovary syndrome by Naderpoor N1, Shorakae S, Joham A, Boyle J, De Courten B, Teede HJ.(PubMed)
(16) Polycystic ovary syndrome: a complex condition with psychological, reproductive and metabolic manifestations that impacts on health across the lifespan by Teede H1, Deeks A, Moran L.(PubMed)
(17) Metabolic Evidence of Diminished Lipid Oxidation in Women WithPolycystic Ovary Syndrome. by Whigham LD1, Butz DE2, Dashti H3, Tonelli M3, Johnson LK1, Cook ME2, Porter WP4, Eghbalnia HR5, Markley JL6, Lindheim SR7, Schoeller DA8, Abbott DH9, Assadi-Porter FM10.(PubMed)
(18) Risk of endometrial, ovarian and breast cancer in women with polycystic ovary syndrome: a systematic review and meta-analysis by Barry JA1, Azizia MM1, Hardiman PJ2.(PubMed)
(19) Risk of cancer among women with polycystic ovary syndrome: a Danish cohort study by Gottschau M1, Kjaer SK2, Jensen A1, Munk C1, Mellemkjaer L3.(PubMed)
(20) Polycystic ovary syndrome: metabolic consequences and long-term management by Carmina E1.(PubMed)
(21) Arterial stiffness is increased in asymptomatic nondiabetic postmenopausal women with a polycystic ovary syndrome phenotype by Armeni E1, Stamatelopoulos K, Rizos D, Georgiopoulos G, Kazani M, Kazani A, Kolyviras A, Stellos K, Panoulis K, Alexandrou A, Creatsa M, Papamichael C, Lambrinoudaki I.(PubMed)
(827a) Diet and nutrition in polycystic ovary syndrome (PCOS): pointers for nutritional management by Farshchi H, Rane A, Love A, Kennedy RL(PubMed)
(828) The optimal diet for women with polycystic ovary syndrome? by Marsh K, Brand-Miller J.(PubMed)
(1065) Popular Herbs - Green Teaby Kyle J. Norton
(1066) The Effect of Green Tea versus Sour Tea on Insulin Resistance, Lipids Profiles and Oxidative Stress in Patients with Type 2 Diabetes Mellitus: A Randomized Clinical Trial by Mozaffari-Khosravi H1, Ahadi Z1, Fallah Tafti M2.(PubMed)
(1067) Effects of green tea extract on insulin resistance and glucagon-like peptide 1 in patients with type 2 diabetes and lipid abnormalities: a randomized, double-blinded, and placebo-controlled trial by Liu CY1, Huang CJ2, Huang LH3, Chen IJ1, Chiu JP1, Hsu CH1.(PubMed)
(1068) Preventive role of green tea catechins from obesity and related disorders especially hypercholesterolemia and hyperglycemia by Ahmad RS1, Butt MS2, Sultan MT3, Mushtaq Z4, Ahmad S5, Dewanjee S6, De Feo V7, Zia-Ul-Haq M8.(PubMed)
(1069) Obesity and thermogenesis related to the consumption of caffeine, ephedrine, capsaicin, and green tea by Diepvens K1, Westerterp KR, Westerterp-Plantenga MS.(PubMed)
(1070) Decaffeinated green tea extract improves hypertension and insulin resistance in a rat model of metabolic syndrome by Ihm SH1, Jang SW, Kim OR, Chang K, Oak MH, Lee JO, Lim DY, Kim JH.(PubMed)
(1071) Prevention of hypertension, cardiovascular damage and endothelial dysfunction with green tea extracts by Antonello M1, Montemurro D, Bolognesi M, Di Pascoli M, Piva A, Grego F, Sticchi D, Giuliani L, Garbisa S, Rossi GP.(PubMed)
(1072) The role of green tea extract and powder in mitigating metabolic syndromes with special reference to h)yperglycemia and hypercholesterolemia by Yousaf S1, Butt MS, Suleria HA, Iqbal MJ.(PubMed)
(1073) Preventive role of green tea catechins from obesity and related disorders especially hypercholesterolemia and hyperglycemia by Ahmad RS1, Butt MS2, Sultan MT3, Mushtaq Z4, Ahmad S5, Dewanjee S6, De Feo V7, Zia-Ul-Haq M8.(PubMed)
(1074) The effect of Ginkgo biloba and Camellia sinensis extracts on psychological state and glycemic control in patients with type 2 diabetes mellitus by Lasaite L, Spadiene A, Savickiene N, Skesters A, Silova A.(PubMed)
(1075) The relationship between green tea and total caffeine intake and risk for self-reported type 2 diabetes among Japanese adults by Iso H1, Date C, Wakai K, Fukui M, Tamakoshi A; JACC Study Group.(PubMed)
(1076) Epigallocatechin gallate (EGCG) suppresses lipopolysaccharide-induced Toll-like receptor 4 (TLR4) activity via 67 kDa laminin receptor (67LR) in 3T3-L1 adipocytes by Bao S1, Cao Y1, Zhou H1, Sun X1, Shan Z1, Teng W1.(PubMed)
(1077) Green tea (-)-epigallocatechin gallate suppresses IGF-I and IGF-II stimulation of 3T3-L1 adipocyte glucose uptake via the glucose transporter 4, but not glucose transporter 1 pathway by Ku HC1, Tsuei YW2, Kao CC2, Weng JT3, Shih LJ3, Chang HH1, Liu CW1, Tsai SW4, Kuo YC5, Kao YH6.(PubMed)
(1078) Green tea epigallocatechin gallate inhibits insulin stimulation of adipocyte glucose uptake via the 67-kilodalton laminin receptor and AMP-activated protein kinase pathways by Hsieh CF1, Tsuei YW, Liu CW, Kao CC, Shih LJ, Ho LT, Wu LY, Wu CP, Tsai PH, Chang HH, Ku HC, Kao YH.(PubMed)
(1079) Effects of Rye Bread Enriched with Green Tea Extract on Weight Maintenance and the Characteristics of Metabolic Syndrome Following Weight Loss: A Pilot Study by Bajerska J1, Mildner-Szkudlarz S, Walkowiak J.(PubMed)
(1080) Vascular and metabolic actions of the green tea polyphenolepigallocatechin gallate by Keske MA, Ng HL, Premilovac D, Rattigan S, Kim JA, Munir K, Yang P, Quon MJ1.(PubMed)
(1081) Effects of the green tea polyphenol epigallocatechin-3-gallate on high-fat diet-induced insulin resistance and endothelial dysfunction by Jang HJ1, Ridgeway SD, Kim JA.(PubMed)
(1082) Effects of dietary supplementation with epigallocatechin-3-gallate on weight loss, energy homeostasis, cardiometabolic risk factors and liver function in obese women: randomised, double-blind, placebo-controlled clinical trial by Mielgo-Ayuso J1, Barrenechea L2, Alcorta P3, Larrarte E4, Margareto J4, Labayen I1.(PubMed)
(1083) Polyphenols: planting the seeds of treatment for the metabolicsyndrome by Cherniack EP1.(PubMed)
(1084) Weight control and prevention of metabolic syndrome by green tea by Sae-tan S1, Grove KA, Lambert JD.(PubMed)
(1085) The potential role of green tea catechins in the prevention of themetabolic syndrome - a review by Thielecke F1, Boschmann M.(PubMed)
(1086) Popular Herbs -Cinnamonby Kyle J. Norton